Lanean...
Targeted Therapies for Melanoma Brain Metastases
Brain metastases are a major clinical challenge occurring in up to 60% of patients suffering from metastatic melanoma. They cause significant clinical symptoms and impair the overall survival prognosis. The introduction of targeted therapies including BRAF and MEK inhibitors as well as CTLA-4 and PD...
Gorde:
| Argitaratua izan da: | Curr Treat Options Neurol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378732/ https://ncbi.nlm.nih.gov/pubmed/28374234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0449-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|